Research and experimental development on natural sciences and engineering
UNI TARGETING RESEARCH AS
Revenue 2024
NOK 3.7m
Operating profit
NOK 563,000
Equity
NOK 3.1m
Incorporated
2001
Share capital
NOK 4.7m
Roles
Daglig lederDagfinn Steinar Øgreid
Styrets lederDagfinn Steinar Øgreid
StyremedlemRoger Løvlie
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| COLOALERT AS | 33.9% | 144628099.000000 | 2025 |
| HANNIBAL INVEST AS | 21.6% | 91975099.000000 | 2025 |
| ROLOGEN AS | 20.0% | 85274242.000000 | 2025 |
| CITRON AS | 20.0% | 85274242.000000 | 2025 |
| PROLUME LTD | 1.7% | 7200000.000000 | 2025 |
| LUCY AS | 1.2% | 5229651.000000 | 2025 |
| UNI TARGETING RESEARCH AS | 0.5% | 2136738.000000 | 2025 |
| CAABY AS | 0.4% | 1538132.000000 | 2025 |
| ENG AS | 0.3% | 1276595.000000 | 2025 |
| FINYIELD AS | 0.2% | 922879.000000 | 2025 |
| BEATE EDITH KATRIN STERN | 0.1% | 489333.000000 | 2025 |
| IAN FRASER PRYME | 0.1% | 379333.000000 | 2025 |
| HANNE RAVNEBERG | 0.0% | 150000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| EUROPEAN ONCOLOGY LAB AS | Active | 100.0% | 30000.000000 |
| UNI TARGETING RESEARCH AS | Active | 0.5% | 2136738.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.